Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management



Status:Recruiting
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:2/24/2018
Start Date:October 2014
End Date:December 2018
Contact:Donna Tepper
Email:dtepper1@hfhs.org
Phone:313-982-8355

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Prospective, Randomized, Controlled Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine For Pain Management After Abdominoplasty and TRAM Flap Breast Reconstruction.

The purpose of this study is to identify the best pain management for patients undergoing
abdominoplasty after massive weight loss or transverse rectus abdominis myocutaneous (TRAM)
flap for breast reconstruction. The investigator is conducting this study to compare the
effectiveness of a continuous infusion pain pump versus a locally injectable long-acting
anesthesia (DepoFoam bupivacaine) versus standard injectable anesthesia (bupivacaine) for
post surgical pain control. These drugs and devices are approved by the FDA (Food and Drug
Administration) for the purpose of pain control after surgery, and have been used for this
purpose before.


Inclusion Criteria:

- Undergoing abdominoplasty or TRAM flap breast reconstruction

Exclusion Criteria:

- A medical condition that could interfere with study participation

- Body weight less than 50 kg

- Participating in another study involving an investigational medication
We found this trial at
1
site
Henry Ford Health System
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials